The favorable price evolution between bare metal stents and drug eluting stents increases the cost effectiveness of drug eluting stents
Published inInternational journal of cardiology, vol. 168, no. 2, p. 1466-1471
Publication date2013
Abstract
Keywords
- Aged
- Cohort Studies
- Cost-Benefit Analysis/methods/trends
- Drug-Eluting Stents/economics/trends
- Female
- Follow-Up Studies
- Humans
- Male
- Metals/economics
- Middle Aged
- Myocardial Revascularization/economics/trends
- Registries
- Risk Factors
- Stents/economics/trends
Research group
Citation (ISO format)
BARONE-ROCHETTE, Gilles et al. The favorable price evolution between bare metal stents and drug eluting stents increases the cost effectiveness of drug eluting stents. In: International journal of cardiology, 2013, vol. 168, n° 2, p. 1466–1471. doi: 10.1016/j.ijcard.2012.12.054
Main files (1)
Article (Published version)
Identifiers
- PID : unige:42490
- DOI : 10.1016/j.ijcard.2012.12.054
- PMID : 23336951
ISSN of the journal0167-5273
